Next 10 |
Summers Value Partners is a boutique value manager that uses a focused, long-term approach to investing in areas of the market where most managers are unwilling or unable to participate. The Summers Value Fund LP gained 14.7% net in 2020, which compares against the Russell 2000 Index ...
ROSELAND, N.J., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (“Emisphere” or the “Company”) today announced the completion of the previously announced transaction whereby Novo Nordisk A/S (“Novo Nordisk”) (NYSE: NVO) acquired ...
WeissLaw LLP Reminds IPHI, EMIS, and EIDX Shareholders About Its Ongoing Investigations NEW YORK , Dec. 4, 2020 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions...
Labaton Sucharow, a nationally ranked shareholder rights firm, is investigating potential securities violations and breach of fiduciary duty claims against pharmaceutical company Emisphere Technologies, Inc. (OTC Ticker: EMIS). If you currently own shares of Emisphere and want to re...
ROSELAND, N.J., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (“Emisphere” or the “Company”) today announced that it has entered into a definitive agreement with Novo Nordisk A/S (“Novo Nordisk”), whereby Novo Nordisk will acquire E...
Summers Value Partners is a boutique value manager that uses a focused, long-term approach to investing in areas of the market where most managers are unwilling or unable to participate. The Summers Value Fund LP declined by 1.2% net during the first nine months of 2020, outpacing the...
Original post Editor's Note : The summary bullets for this article were chosen by Seeking Read more ...
Expanding horizons Novo Nordisk ( NVO ) is taking the next logical step in doing what a growth stock has to do, namely expanding its TAM (total available market). NVO was formed by the merger of two leading, neighboring diabetes-focused companies. In the 2010's, it expanded its horizons by f...
ROSELAND, N.J., April 06, 2020 (GLOBE NEWSWIRE) -- Novo Nordisk announced the European Commission (EC) has granted marketing authorization for Rybelsus®, (oral semaglutide), for the treatment of adults with insufficiently controlled type 2 diabetes to improve glycemic control as an adj...
Overview With the equity markets trading at near record valuations, we’ve been actively looking for mispriced idiosyncratic opportunities, with the hope to find equity -like returns without equity risk. We believe that Merrimack Pharmaceuticals is such an investment. If we are right...
News, Short Squeeze, Breakout and More Instantly...
Emisphere Technologies, Inc. Company Name:
EMIS Stock Symbol:
OTCMKTS Market:
ROSELAND, N.J., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (“Emisphere” or the “Company”) today announced the completion of the previously announced transaction whereby Novo Nordisk A/S (“Novo Nordisk”) (NYSE: NVO) acquired ...
Labaton Sucharow, a nationally ranked shareholder rights firm, is investigating potential securities violations and breach of fiduciary duty claims against pharmaceutical company Emisphere Technologies, Inc. (OTC Ticker: EMIS). If you currently own shares of Emisphere and want to re...
ROSELAND, N.J., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (“Emisphere” or the “Company”) today announced that it has entered into a definitive agreement with Novo Nordisk A/S (“Novo Nordisk”), whereby Novo Nordisk will acquire E...